Filing Details

Accession Number:
0001179110-10-000628
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-01-06 12:00:00
Reporting Period:
2010-01-04
Filing Date:
2010-01-06
Accepted Time:
2010-01-06 17:37:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
882095 Gilead Sciences Inc GILD Biological Products, (No Disgnostic Substances) (2836) 943047598
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1334682 H Gregg Alton Gilead Sciences, Inc.
333 Lakeside Drive
Foster City CA 94404
Evp, Corp & Med Affairs No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-01-04 5,000 $15.27 23,056 No 4 M Direct
Common Stock Disposition 2010-01-04 5,000 $43.33 18,056 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (rght to buy) Disposition 2010-01-04 5,000 $0.00 5,000 $15.27
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
109,000 2014-01-28 No 4 M Direct
Footnotes
  1. The options have a 5 year vesting schedule. 20% of the options vested on January 28, 2005, the first anniversary of the date of the grant. The balance vested 5% every three months thereafter until fully vested on January 28, 2009. The options expire on January 28, 2014.
  2. Sale prices reported for the transaction reported here range from $43.16 to $43.50. Full information regarding the number of shares purchased or sold at each price will be provided to the SEC, the issuer or its shareowners upon request.